Search - tctmd.com

Displaying 621 - 640 of 674

Sort: Relevancy | Date

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Yael L. Maxwell

September 26, 2011

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

September 02, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Conference News

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

August 30, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

Advertisement

Six Months Sufficient for Dual Antiplatelet Therapy

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Antiplatelet Therapy Plus SSRI Spurs Bleeding After MI

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

ESC Congress 2011: Drugs, Devices Work Together

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

Halting Clopidogrel in First Year Following Acute MI Hazardous

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Long-term Antiplatelet Therapy: All Risk, No Benefit

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Poor Association Between Stent Thrombosis, Platelet Function Tests

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

After GRAVITAS: Is There a Future for Functional Platelet Testing?

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content